Sankyo

Erik S. Lesser/Getty Images News Merck (NYSE:MRK) announced Thursday an agreement with Japanese pharma Daiichi Sankyo (OTCPK:DSKYF) to jointly develop and commercialize three antibody-drug conjugates (ADC) targeted at solid tumors. The…